FDA Inspection 633400 — Rubin (Nmi) Zhang Md
The FDA completed an inspection of Rubin (Nmi) Zhang Md on Dec 8, 2009 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Orleans, LA (United States)
Additional Details
Clinical Investigator (CI)